HDR Gateway logo
HDR Gateway logo

Bookmarks

General Cancer And Cancer Registeries

General Cancer and Cancer Registeries

Description

This collection brings together resources listed on the Innovation Gateway that are general cancer registries or cover more than one type of cancer.

Datasets & BioSamples (62)

Yorkshire Specialist Register of Cancer in Children and Young People
Dataset population size: 11,000
Health and disease
Leeds-IQVIA Collaboration
Dataset population size: Unknown
Health and disease
Real Time Data Network (RTDN)
Dataset population size: 10,000
Health and disease
PHM and Cancer Outcomes in the WYH Cancer Alliance
Dataset population size: Unknown
Health and disease
Comprehensive Patient Records for Cancer Outcomes
Dataset population size: 40,000
Health and disease
Children’s Kidney Cancers - Great Ormond Street Hospital
Dataset population size: 650
Health and disease

Publications (8)

Estimated impact of the COVID-19 pandemic on cancer services and excess 1-year mortality in people with cancer and multimorbidity: near real-time data on cancer care, cancer deaths and a population-based cohort study.
Lai AG, Pasea L, Banerjee A, Hall G, Denaxas S, Chang WH, Katsoulis M, Williams B, Pillay D, Noursadeghi M, Linch D, Hughes D, Forster MD, Turnbull C, Fitzpatrick NK, Boyd K, Foster GR, Enver T, Nafilyan V, Humberstone B, Neal RD, Cooper M, Jones M, Pritchard-Jones K, Sullivan R, Davie C, Lawler M, Hemingway H.
2020
The impact of the COVID-19 pandemic on radiotherapy services in England, UK: a population-based study.
Spencer K, Jones CM, Girdler R, Roe C, Sharpe M, Lawton S, Miller L, Lewis P, Evans M, Sebag-Montefiore D, Roques T, Smittenaar R, Morris E.
2021
ONCOR: design of the Dutch cardio-oncology registry.
Kamphuis JAM, Linschoten M, Cramer MJ, Alsemgeest F, van Kessel DJW, Urgel K, Post MC, Manintveld OC, Hassing HC, Liesting C, Wardeh AJ, Olde Bijvank EGM, Schaap J, Stevense-den Boer AM, Doevendans PA, Asselbergs FW, Teske AJ.
2021
Estimating excess mortality in people with cancer and multimorbidity in the COVID-19 emergency
Lai AG, Pasea L, Banerjee A, Denaxas S, Katsoulis M, Chang WH, Williams B, Pillay D, Noursadeghi M, Linch D, Hughes D, Forster MD, Turnbull C, Fitzpatrick NK, Boyd K, Foster GR, Cooper M, Jones M, Pritchard-Jones K, Sullivan R, Hall G, Davie C, Lawler M, Hemingway H.
2020
Circulating inflammatory cytokines and risk of five cancers: a Mendelian randomization analysis.
Bouras E, Karhunen V, Gill D, Huang J, Haycock PC, Gunter MJ, Johansson M, Brennan P, Key T, Lewis SJ, Martin RM, Murphy N, Platz EA, Travis R, Yarmolinsky J, Zuber V, Martin P, Katsoulis M, Freisling H, Nøst TH, Schulze MB, Dossus L, Hung RJ, Amos CI, Ahola-Olli A, Palaniswamy S, Männikkö M, Auvinen J, Herzig KH, Keinänen-Kiukaanniemi S, Lehtimäki T, Salomaa V, Raitakari O, Salmi M, Jalkanen S, PRACTICAL consortium, Jarvelin MR, Dehghan A, Tsilidis KK.
2022